World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
85278
World Ranking
4109
National Ranking
40

Overview

Richard Sylvester is affiliated with the European Organisation for Research and Treatment of Cancer in Belgium. Their research primarily focuses on medicine, with a significant concentration in surgery, neurology, epidemiology, oncology, and urology. The main topics of their work include bladder and urothelial cancer treatments, urinary and genital oncology studies, esophageal cancer research and treatment, traumatic brain injury research, urological disorders and treatments, traumatic brain injury and neurovascular disturbances, and colorectal cancer screening and detection.

Their recent scholarly contributions include publications in peer-reviewed journals such as European Urology, European Urology Oncology, and Brain. Notable papers are:

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ), 2021, European Urology
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update, 2020, European Urology
  • European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel, 2021, European Urology
  • Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study, 2021, European Urology Oncology
  • COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database, 2022, Brain

Frequent coauthors collaborating with Sylvester include:

  • Paolo Gontero
  • Joan Palou
  • Morgan Rouprêt
  • Shahrokh F. Shariat
  • Éva Compérat

Their work appears predominantly in the following publication venues:

  • European Urology
  • European Urology Oncology
  • Brain
  • Journal of Neurology Neurosurgery & Psychiatry
  • The Journal of Urology

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

    Richard J. Sylvester;Adrian P.M. van der Meijden;Willem Oosterlinck;J. Alfred Witjes

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

    Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun

  • Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

    G H J Mickisch;A Garin;H van Poppel;L de Prijck

  • Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

    Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand

  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

    GM Mead;SP Stenning;P Cook;SD Fossa

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat

  • [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

    M. Babjuk;W. Oosterlinck;R. Sylvester;E. Kaasinen

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

    Francesco Pignatti;Martin van den Bent;Desmond Curran;Channa Debruyne

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero

  • International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

    Gareth Griffiths;Reginald Hall;Richard Sylvester;Derek Raghavan

  • Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

    O Dalesio;H van Tinteren;M Clarke;R Peto

  • Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

    JF Tierney;Richard J. Sylvester

  • A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

    Hendrik Van Poppel;Luigi Da Pozzo;Walter Albrecht;Vsevolod Matveev

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Otakar Capoun;Daniel Cohen

  • EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

    Marko Babjuk;Willem Oosterlinck;Richard Sylvester;Eero Kaasinen

  • Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

    Maria De Santis;Joaquim Bellmunt;Graham Mead;J. Martijn Kerst

Frequent Co-Authors

Laurence Collette
Laurence Collette European Organisation for Research and Treatment of Cancer
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Armando Santoro
Armando Santoro Humanitas University
J. Alfred Witjes
J. Alfred Witjes Radboud University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Steven Joniau
Steven Joniau KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are numerous alternative pathways for those interested in healthcare professions beyond a traditional medical degree. For example, adn nursing programs offer a practical route to becoming a registered nurse in a shorter timeframe, often with flexible admission requirements.

If direct patient care isn’t your preference, consider options like medical billing and coding schools online with financial aid. These programs can be completed remotely and prepare graduates for vital administrative roles in healthcare, often with financial assistance available.

Accelerated and streamlined nursing tracks are available, too. Some students opt for an lpn program without teas test requirements, making entry into nursing even more accessible.

Lastly, for those interested in leadership, an administrative path—like pursuing the best online healthcare administration degree—equips graduates to manage teams and healthcare systems. Exploring these related degrees can expand your career options within the healthcare field.

Best Scientists Citing Richard Sylvester

Trending Scientists

Recently Published Articles